Full-Time

Head of Platform Delivery

Posted on 3/13/2025

Takeda

Takeda

10,001+ employees

Global biopharmaceutical company focused on R&D

Compensation Overview

$224.1k - $275.6kAnnually

Senior, Expert

Cambridge, MA, USA + 1 more

More locations: Boston, MA, USA

Up to 30% remote work allowed.

Category
IT Project Management
IT & Security
Required Skills
Power BI
Requirements
  • Bachelor’s degree in Computer Science, Computer Information Systems or related field
  • 8 years of prior experience
  • Lead and manage resources to provide operational support for the Microsoft 365 suite, including SharePoint, MS Teams, Stream, Viva Engage, OneDrive, Security and Compliance, Azure AD, and other related applications
  • Utilize proficiency in Microsoft Power Platform, including Power Apps, Power Automate, and Power BI
  • Apply familiarity with Box, a cloud content management and collaboration platform
  • Demonstrate strong problem-solving skills to address complex issues
Responsibilities
  • Lead and enhance technical operations across the Digital Workplace team, with a focus on Microsoft 365, SharePoint, Teams, Viva Engage, Power Platform, and Box
  • Drive the evolution of the Business and Technical Operations Team and Platform, and leading Change Management Teams
  • Provide expert guidance and leadership, leverage knowledge of technical operations to identify and address operational needs, problems, and opportunities
  • Coach and lead project teams in the development and implementation of complex systems, align with strategic goals in a cost-effective manner
  • Influence decisions that impact organizational goals, financial performance, and the work of employing organizations
  • Demonstrate expertise and leadership in large/complex areas of work, encompass technical, financial, and quality aspects
  • Represent the organization and sharing new industry standards and trends with peers
  • Act as a subject matter expert, translate understanding of digital products to the organization's IT landscape and strategic plans

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and commercialize them, with a goal of launching up to 15 products by FY2024. Takeda serves healthcare providers, hospitals, and patients worldwide, ensuring that patient needs are prioritized in their operations. Unlike many competitors, Takeda emphasizes a long-term commitment to both innovation and environmental sustainability, recognizing the connection between environmental health and human health. Their goal is to provide life-changing therapies while maintaining a strong pipeline of new products and fostering partnerships with suppliers globally.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...